They are talking about us! Allurion's newsroom

BBC
bloomberg
Daily Mail
Forbes
Tech Crunch
The Boston Globe
The Guardian
The wall street journal
Scientific American
Good Morning Britain
The New-York Times
Une technique gonflée à la polyclinique de l’Ormeau

Une technique gonflée à la polyclinique de l’Ormeau

Perdre 10 à 15 kg en 16 semaines, sans chirurgie, cela va être désormais possible dans les Hautes-Pyrénées. La polyclinique de l’Ormeau adopte le ballon Elipse, dispositif gastrique innovant. Niché dans une capsule végétale (2 cm environ), relié à un cathéter, le ballon est avalé par le patient. 

Pau : un nouveau ballon pour venir à bout de l’obésité

Pau : un nouveau ballon pour venir à bout de l’obésité

LA REPUBLIQUE DES PYRENEES - Unique dans la région ! L’équipe de la polyclinique de Navarre des Drs Miguet et Larroudé, chirurgiens digestifs, et Aline Fabre diététicienne nutritionniste, soutenus par Hélène Rousseau psychologue et Samuel Brethous coach sportif, proposent un nouveau dispositif pour la prise en charge du surpoids et de l’obésité : le ballon intragastrique Elipse

A weight off - an Elipse patient case study

A weight off - an Elipse patient case study

AESTHETIC MEDICINE - Commenting on his results, Jones said: “The balloon has focused my mind again and made me want to live a healthier life. It has got me back into the gym and making better choices about what I’m eating.”

Allurion Technologies Announces 1 Million Pound Challenge in Celebration of World Obesity Day

Allurion Technologies Announces 1 Million Pound Challenge in Celebration of World Obesity Day

BUSINESS WIRE - Allurion Technologies, an established leader in the development of innovative, proven, and trusted weight loss experiences, today—on World Obesity Day—announced its commitment to treat 40,000 individuals around the world and shed over one million pounds by the end of 2020. “People all over the world are embracing the convenience and effectiveness of our novel approach to weight loss,” said Shantanu Gaur, M.D., co-founder and CEO of Allurion Technologies, Inc. “On World Obesity Day, we celebrate the success of those whose lives have changed as a result of the Elipse Program and set a bold goal for our company for the year ahead.”

How can we help?

We’re here to answer any questions you may have.

This website describes our product, which has not been approved or cleared for marketing by the U.S. Food and Drug Administration and is considered an investigational device. Our product is not available for sale in the United States. This website also has a Privacy Policy and Terms of Use that may reflect the laws and practices in other countries and jurisdictions, which may differ from those in the United States. We encourage you to review the Privacy Policy and Terms of Use.
APM003 REV 1 DCO0089

I understand